Tuberculosis drug discovery gets smarter with AI
Researchers at Texas A&M University are developing AI tools to streamline the drug discovery process for tuberculosis. By organizing collaborative data and prioritizing promising compounds, the team aims to reduce the time and cost required to bring new treatments to market.
Why it matters
Tuberculosis remains a leading global health threat, and AI-driven innovation could significantly accelerate the development of life-saving therapies.
edited by Lisa Lock , reviewed by Andrew Zinin
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in